metformin has been researched along with srt2104 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baksi, A; Elliott, P; Haddad, J; Hoffmann, E; Jacobson, EW; Kraydashenko, O; Stets, R; Vlasuk, GP; Zalevkaya, A | 1 |
1 trial(s) available for metformin and srt2104
Article | Year |
---|---|
A phase II, randomized, placebo-controlled, double-blind, multi-dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Enzyme Activation; Enzyme Activators; Female; Heterocyclic Compounds, 2-Ring; Humans; Insulin; Male; Metformin; Middle Aged; Sirtuin 1 | 2014 |